Butorphanol and Nalmefene interaction

Butorphanol and Nalmefene: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Butorphanol (Butorphanol Tartrate) label · effective 2026-01-02

Major

Management of respiratory depression may include close observation, supportive measures, and use of opioid overdose reversal agents (e.g., naloxone, nalmefene), depending on the patient's clinical status [see OVERDOSAGE ].

Warningsnames NalmefeneView label on DailyMed
Moderate

If concomitant use is warranted, consider ‎prescribing naloxone for the emergency treatment of opioid overdose.

Drug interactionsby drug classView label on DailyMed
Minor

In patients who are not opioid dependent, naloxone has also been reported to be effective.

Warningsby drug classView label on DailyMed

From the Nalmefene (Zurnai) label · effective 2026-07-31

Major

Risk of Recurrent Respiratory and CNS Depression : A recurrence of respiratory depression is possible, therefore, keep the patient under continued surveillance and administer repeat doses of ZURNAI using a new auto-injector with each dose while awaiting emergency medical assistance.

Warnings and precautionsby drug classView label on DailyMed
Major

In neonates, opioid withdrawal may be life-threatening if not recognized and properly treated.

Warnings and precautionsby drug classView label on DailyMed
Major

While the duration of action of nalmefene is as long as most opioids, a recurrence of respiratory depression is possible, even after an apparently adequate initial response to ZURNAI treatment [see Clinical Pharmacology (12.3) ].

Warnings and precautionsby drug classView label on DailyMed
Major

In neonates, opioid withdrawal may be life-threatening if not recognized and properly treated and may include the following signs and symptoms: convulsions, excessive crying, and hyperactive reflexes.

Warnings and precautionsby drug classView label on DailyMed
Major

There may be clinical settings, particularly the postpartum period in neonates with known or suspected exposure to maternal opioid use, where it is preferable to avoid the abrupt precipitation of opioid withdrawal symptoms.

Warnings and precautionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.